spacer
home > pmps > summer 2019 > scandinavian sciences
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Scandinavian Sciences

The pharmaceutical industry is one of the major industries in Scandinavia, particularly in Denmark and Sweden. These two countries are home to the Medicon Valley and the Danish biotechnology sector. The cluster spans the eastern part of Denmark, including Copenhagen, and the south-western part of Sweden and is connected via the Řresund Bridge. As one of Europe’s top three pharma and biotech clusters (alongside Cambridge in the UK and Basel in Switzerland), it is no wonder Medicon Valley attracts a constant stream of researchers and investors.

The Danish pharma industry is known worldwide for providing quality drugs and other medical products and is also a key sector of the local economy, employing about 20,000 people; this is the same for the pharma industry and its suppliers in neighbouring Sweden (1). Including indirect employment, the pharma industry in Denmark provides up to 70,000 jobs, with 300 pharma-related companies established in the region (2). Major international companies with research centres in the area include Novo Nordisk, Baxter, Lundbeck, LEO Pharma, HemoCue, and Ferring Pharmaceuticals. Measured by the number of employees relative to the size of the population, Denmark has the second largest pharma industry in the world. In 2012, Denmark was the eighth largest producer of pharmaceutical products in the EU, accounting for 4.1% of the total EU production (3).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Zdeněk Pečený studied Finance and Financial Services at the University of Finance and Administration in Prague and has 10 years of work experience for various media outlets specialising in finance and business points of view. Zdeněk is based between London and Prague and has worked as a freelance journalist for three years while travelling and networking, gaining a greater understanding of attitudes of people and governments particularly to business and healthcare.
spacer
Zdeněk Pečený
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019

Ahead of the 2019 HPAPI USA Conference taking place in Boston on 21st – 22nd October, SMi caught up with Richard Arnett, Manager, Industrial Hygiene, Pharmascience who is speaking on Day Two of the agenda. Richard shared his thoughts on how the industry has developed and briefly touched on what he will be discussing in October.
More info >>

White Papers

Data Technology as a Catalyst for Growth in the Life Sciences

AIGENPULSE

The life sciences industry is changing at a rapid pace. The need to develop the next blockbuster is pushing current technologies and methodologies to the limit. Scientific advancement over the last decades was embossed with giant leaps in knowledge, however, the new reality is that smaller incremental gains need to be carved out with ever increasing investments. In order to survive, progress and prosper in this new reality, a holistic approach to getting the most of research data is crucial. In fact, it will likely be the difference of being in existence in 5-10 years or not. For those bold enough to step into an area they are unfamiliar with, huge rewards are waiting.
More info >>

 
Industry Events

SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)

11-13 May 2020, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020. HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement